Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oh

Showing results (201-210 of 552) with videos related to

Pageof 56
Sort By:
Oncogene|April 21, 2015
Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cellsS Li, Y-T Oh, P Yue, et al.
Anticancer Research|November 1, 1989
Molecular species of the antitumor and antiviral fraction from pine cone extractH Sakagami, T Oh-Hara, T Kaiya, et al.
The Journal of Dermatology|December 6, 2001
The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosusA Tanaka, M Igarashi, M Kakinuma, et al.
The Medical Journal of Australia|September 18, 1982
Advanced extrauterine pregnancyY Stokes, G Braimbridge, D Kermode, et al.
Clinical & Experimental Metastasis|March 1, 1990
Inhibition of lung colonization of mouse colon 26 adenocarcinoma by recombinant mouse interferon beta through a modification of platelet functionT Tsuruo, H Saito, M Watanabe, et al.
Cancer Research|August 15, 1987
Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potentialY Sugimoto, T Oh-hara, M Watanabe, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasisT Hirano, K Oka, Y Umezawa, et al.
Leukemia|August 21, 2010
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutationsA Pardanani, T Lasho, C Finke, et al.
International Journal of Laboratory Hematology|June 14, 2024
Pseudo-lymphocytosis caused by circulating megakaryocyte fragments in a patient with post-essential thrombocythemia myelofibrosisHomayemem Weli, John L Frater, Gail Shimer, et al.
Cancer Research|February 1, 1991
Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregationY Sugimoto, M Watanabe, T Oh-hara, et al.
Pageof 56

Showing results (201-210 of 552) with videos related to

Sort By:
Pageof 56
Oncogene|April 21, 2015
Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cellsS Li, Y-T Oh, P Yue, et al.
Anticancer Research|November 1, 1989
Molecular species of the antitumor and antiviral fraction from pine cone extractH Sakagami, T Oh-Hara, T Kaiya, et al.
The Journal of Dermatology|December 6, 2001
The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosusA Tanaka, M Igarashi, M Kakinuma, et al.
The Medical Journal of Australia|September 18, 1982
Advanced extrauterine pregnancyY Stokes, G Braimbridge, D Kermode, et al.
Clinical & Experimental Metastasis|March 1, 1990
Inhibition of lung colonization of mouse colon 26 adenocarcinoma by recombinant mouse interferon beta through a modification of platelet functionT Tsuruo, H Saito, M Watanabe, et al.
Cancer Research|August 15, 1987
Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potentialY Sugimoto, T Oh-hara, M Watanabe, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasisT Hirano, K Oka, Y Umezawa, et al.
Leukemia|August 21, 2010
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutationsA Pardanani, T Lasho, C Finke, et al.
International Journal of Laboratory Hematology|June 14, 2024
Pseudo-lymphocytosis caused by circulating megakaryocyte fragments in a patient with post-essential thrombocythemia myelofibrosisHomayemem Weli, John L Frater, Gail Shimer, et al.
Cancer Research|February 1, 1991
Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregationY Sugimoto, M Watanabe, T Oh-hara, et al.
Pageof 56